Fitbit has completed clinical trials of its own ECG feature and is looking to get FDA approval – as it launches a large scale study into Afib and irregular heart rate detection. The mass Fitbit Heart ...
Sept. 24 (UPI) --Changes in heart function observed on electrocardiograms of patients hospitalized with COVID-19 or influenza can help predict a time frame for worsening health, a study published ...
France: The findings of a new study published in JAMA Cardiology suggest that an electrophysiological study (EPS) provides ...
Even minor ECG abnormalities detected with annual checks signal a greater risk of future CVD events, a study of several million working-age people affirms, although questions remain about whether ...
A study published in Nature Medicine reports the ability of a smartwatch ECG to accurately detect heart failure in nonclinical environments. Researchers at Mayo Clinic applied artificial intelligence ...
HeartBeam’s synthesised 12-lead electrocardiogram (ECG) has met the clinical endpoints in the VALID-ECG pivotal study, assessing non-life-threatening arrhythmias. In the study, the mean difference in ...
Please provide your email address to receive an email when new articles are posted on . Abnormal ECG findings were rare in elite female basketball players. These data may serve as a reference for ...
A new study published in the journal of Clinical Cardiology revealed that acoustic cardiography (ACG), which combines ECG ...
Cardiologists regularly get calls from people who are freaked out by the fitness tracker on their wrist. Typically, the caller is young and healthy, maybe even a half-marathoner, says Cleveland Clinic ...
ECG abnormalities detected as part of a cardiac screening program mandated by the National Basketball Association (NBA) were found in 15.6% of active players and potential draftees, a new analysis ...
Implementing large-scale ECG screening before high school sport participation could detect heart abnormalities that carry the risk of sudden cardiac death if left unchecked, a researcher reported.
AccurKardia, an innovator in ECG-based diagnostics technology, has announced the initiation of a multicenter clinical pilot of AK+ GuardTM, an FDA Breakthrough Device Designated AI-powered technology ...